Skip to content

Cross-sectional Study of Fibromyalgia

A Cross-sectional Study of Fibromyalgia in Beijing

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02449395
Enrollment
124
Registered
2015-05-20
Start date
2015-04-30
Completion date
2018-03-31
Last updated
2018-11-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fibromyalgia

Brief summary

This study is designed to collect data on precipitating factors, diagnosis, morbidity, therapy, quality of life, and symptom severity, etc. informations in patients with fibromyalgia.

Detailed description

Patients fulfilling 1990 ACR criterion for fibromyalgia will be recruited in Fibromyalgia outpatient service which is belonged to the Department of Rheumatism. Except collecting patients' demographic and social characteristic informations, rheumatologist also carry out a comprehensive evaluation including patient current history, current medication use, and tender point examination for a diagnosis or confirmation of fibromyalgia and treatment recommendations. Patients with fibromyalgia will be asked to fill a set of questionnaires to evaluate their quality of life, symptoms severity, quality of sleep and emotion. The study will be conducted in Beijing, China.

Interventions

None listed

Sponsors

Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Age 18 years or older. * Fulfills the American College of Rheumatology (ACR) 1990 classification criteria for Fibromyalgia.

Exclusion criteria

* Don't fulfill any classification criterions for Fibromyalgia.

Design outcomes

Primary

MeasureTime frame
Fibromyalgia symptoms severity as measured by Fibromyalgia Impact Questionnaire (FIQ)up to 1 week

Secondary

MeasureTime frame
Pain scores as measured by Numerical rating scale (NRS)up to 1 week
Fatigue scores as measured by Multidimensional Assessment Fatigue (MAF)up to 1 week
QOL as measured by Short Form-36 Health Status Questionnaire (SF-36)up to 1 week
Stress scores as measured by Perceived Stress Scale (PSS)up to 1 week
Sleep scores as measured by Pittsburgh sleep quality index (PSQI)up to 1 week
Depression scores as measured by Beck depression inventory (BDI)up to 1 week

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 6, 2026